Literature DB >> 8948674

Cold agglutinin hemolysis responding to fludarabine therapy.

A Jacobs.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8948674     DOI： 10.1002/(SICI)1096-8652(199612)53:4<279::AID-AJH17>3.0.CO;2-7

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  3 in total

1.  Efficacy of rituximab-bendamustine in cold agglutinin haemolytic anaemia refractory to previous chemo-immunotherapy: a case report.

Authors:  Angela Gueli; Daniela Gottardi; Huijing Hu; Irene Ricca; Alberto De Crescenzo; Corrado Tarella
Journal:  Blood Transfus       Date:  2013-01-22       Impact factor: 3.443

2.  Rituximab-containing therapy for cold agglutinin disease: a retrospective study of 16 patients.

Authors:  Ming-Nan Jia; Yu Qiu; Yan-Yan Wu; Hao Cai; Dao-Bin Zhou; Xin-Xin Cao; Jian Li
Journal:  Sci Rep       Date:  2020-07-29       Impact factor: 4.379

Review 3.  Primary chronic cold agglutinin disease: an update on pathogenesis, clinical features and therapy.

Authors:  Sigbjørn Berentsen; Klaus Beiske; Geir E Tjønnfjord
Journal:  Hematology       Date:  2007-10       Impact factor: 2.269
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.